Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic N-acetylcysteine and dexamethasone to prevent cisplatin-induced ototoxicity
TCTR20160314003Phase 0Completed
- Sponsor
- Student Research Committee
- Start
- Feb 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, double-blind trial of acetylcysteine and dexamethasone in cisplatin-induced ototoxicity, sponsored by Student Research Committee. Started Feb 2013; status: completed.
02
Drugs
acetylcysteinedexamethasone
03
Conditions
cisplatin-induced ototoxicity
Beyond the preview
Go deeper on TCTR20160314003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160314003.